Literature DB >> 7856752

Cytokine mRNA expression in postischemic/reperfused myocardium.

A Herskowitz1, S Choi, A A Ansari, S Wesselingh.   

Abstract

While the role of cytokines in mediating injury during hind limb skeletal muscle ischemia followed by reperfusion has recently been described, the role of cytokines in myocardial infarction and ischemia/reperfusion have remained relatively unexplored. We hypothesize that cytokines play an important role in the regulation of postischemic myocardial inflammation. This study reports the temporal sequence of proinflammatory cytokine gene expression in postischemic/reperfused myocardium and localizes interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha)-protein by immunostaining. Rats were subjected to either permanent left anterior descending (LAD) occlusion or to 35 minutes of LAD occlusion followed by reperfusion and sacrificed up to 7 days later. Rat-specific oligonucleotide probes were used to semiquantitatively assess the relative expression of mRNA for TNF-alpha, IL-1 beta, IL-2, IL-6, interferon-gamma (IFN-gamma), and transforming growth factor-beta 1 (TGF-beta 1) utilizing the reverse transcriptase-polymerase chain reaction amplification technique. Increased cardiac mRNA levels for all cytokines except IL-6 and IFN-gamma were measurable within 15 to 30 minutes of LAD occlusion and increased levels were generally sustained for 3 hours. During early reperfusion, mRNA levels for IL-6 and TGF-beta 1 were significantly reduced compared with permanent LAD occlusion. In both groups, cytokine mRNA levels all returned to baseline levels at 24 hours, while IL-1 beta, TNF-alpha, and TGF-beta 1 mRNA levels again rose significantly at 7 days only in animals with permanent LAD occlusion. Immunostaining for IL-1 beta and TNF-alpha protein revealed two patterns of reactivity: 1) microvascular staining for both IL-1 beta and TNF-alpha protein only in postischemic reperfused myocardium in early post-reperfusion time points; and 2) staining of infiltrating macrophages in healing infarct zones which was most prominent at 7 days after permanent LAD occlusion. These results provide evidence for local expression of cytokine mRNA in postischemic myocardium and suggest that regulation of local cytokine release is altered during the postischemic period.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856752      PMCID: PMC1869839     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Cellular mechanisms of myocardial infarct expansion.

Authors:  H F Weisman; D E Bush; J A Mannisi; M L Weisfeldt; B Healy
Journal:  Circulation       Date:  1988-07       Impact factor: 29.690

2.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

3.  Cytokines induce stress protein formation in cultured cardiac myocytes.

Authors:  I Löw-Friedrich; D Weisensee; P Mitrou; W Schoeppe
Journal:  Basic Res Cardiol       Date:  1992 Jan-Feb       Impact factor: 17.165

4.  Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.

Authors:  H Schunkert; V J Dzau; S S Tang; A T Hirsch; C S Apstein; B H Lorell
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

5.  Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.

Authors:  A T Hirsch; C E Talsness; H Schunkert; M Paul; V J Dzau
Journal:  Circ Res       Date:  1991-08       Impact factor: 17.367

6.  Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion.

Authors:  K Youker; C W Smith; D C Anderson; D Miller; L H Michael; R D Rossen; M L Entman
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

7.  Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.

Authors:  J S Pober; L A Lapierre; A H Stolpen; T A Brock; T A Springer; W Fiers; M P Bevilacqua; D L Mendrick; M A Gimbrone
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

8.  Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart.

Authors:  K A Youker; H K Hawkins; G L Kukielka; J L Perrard; L H Michael; C M Ballantyne; C W Smith; M L Entman
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

9.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.

Authors:  H F Weisman; T Bartow; M K Leppo; H C Marsh; G R Carson; M F Concino; M P Boyle; K H Roux; M L Weisfeldt; D T Fearon
Journal:  Science       Date:  1990-07-13       Impact factor: 47.728

10.  Steroid administration after myocardial infarction promotes early infarct expansion. A study in the rat.

Authors:  J A Mannisi; H F Weisman; D E Bush; P Dudeck; B Healy
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

View more
  76 in total

Review 1.  Apoptosis in myocardial ischaemia and infarction.

Authors:  P A J Krijnen; R Nijmeijer; C J L M Meijer; C A Visser; C E Hack; H W M Niessen
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

2.  Detection of circulating epithelial cells after surgery for benign breast disease.

Authors:  D Crisan; D S Ruark; D A Decker; A M Drevon; R G Dicarlo
Journal:  Mol Diagn       Date:  2000-03

Review 3.  Insights into the monomers and single drugs of Chinese herbal medicine on myocardial preservation.

Authors:  Shi-Min Yuan; Hua Jing
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-12-30

4.  Dichotomous actions of NF-kappaB signaling pathways in heart.

Authors:  Rimpy Dhingra; James A Shaw; Yaron Aviv; Lorrie A Kirshenbaum
Journal:  J Cardiovasc Transl Res       Date:  2010-05-25       Impact factor: 4.132

5.  Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.

Authors:  Sean van Diepen; Matthew T Roe; Renato D Lopes; Amanda Stebbins; Stefan James; L Kristin Newby; David J Moliterno; Franz-Josef Neumann; Justin A Ezekowitz; Kenneth W Mahaffey; Judith S Hochman; Christian W Hamm; Paul W Armstrong; Pierre Theroux; Christopher B Granger
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

Review 6.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

7.  Pattern of superoxide dismutase enzymatic activity and RNA changes in rat heart ventricles after myocardial infarction.

Authors:  M Assem; J R Teyssier; M Benderitter; J Terrand; A Laubriet; A Javouhey; M David; L Rochette
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

8.  Pathways involved in interleukin-1β-mediated murine cardiomyocyte apoptosis.

Authors:  Yi Shen; Jie Qin; Peili Bu
Journal:  Tex Heart Inst J       Date:  2015-04-01

9.  Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.

Authors:  John Doukas; Wolfgang Wrasidlo; Glenn Noronha; Elena Dneprovskaia; Richard Fine; Sara Weis; John Hood; Anthony Demaria; Richard Soll; David Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

Review 10.  Fibroblasts in myocardial infarction: a role in inflammation and repair.

Authors:  Arti V Shinde; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2013-12-07       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.